LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...

Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether their inhaler needed to be returned. The call comes after the Medicines and Healthcare ...

A year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers faced significant distress due to the medication’s scarcity, ...